Exposure of LuCaP 136 tumor-bearing mice to ganetespib and biomarker analysis after 24 or 48 hours paralleled the in vitro biomarker changes including decreased AR, p-AKT, and p-RPS6 and increased HSP70 (Fig. 6B). This evidence concerns the gene AR and neoplasm.